Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

SELL
$230.71 - $256.74 $22,609 - $25,160
-98 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$219.27 - $242.57 $21,488 - $23,771
98 New
98 $23,000
Q4 2018

Feb 04, 2019

SELL
$178.4 - $208.25 $1,784 - $2,082
-10 Closed
0 $0
Q3 2018

Oct 17, 2018

BUY
$185.29 - $208.89 $1,852 - $2,088
10 New
10 $2,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Parkside Investments, LLC Portfolio

Follow Parkside Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Investments, LLC with notifications on news.